Capital Markets Q2 2023 Perspectives: Healthcare in Focus

July 17, 2023

Healthcare in the spotlight

With a general slowdown in M&A and Capital Markets activity, pharma and biotech are leading the charge with large announced deals, successful acquisition financings and evidence of green shoots seen in the equity capital markets. Hear from our experts on what is driving the sector activity and what we expect for the remainder of the year.

Back to top